Prostate Cancer - Hope Is Not A Strategy
Book file PDF easily for everyone and every device.
You can download and read online Prostate Cancer - Hope Is Not A Strategy file PDF Book only if you are registered here.
And also you can download or read online all Book PDF file that related with Prostate Cancer - Hope Is Not A Strategy book.
Happy reading Prostate Cancer - Hope Is Not A Strategy Bookeveryone.
Download file Free Book PDF Prostate Cancer - Hope Is Not A Strategy at Complete PDF Library.
This Book have some digital formats such us :paperbook, ebook, kindle, epub, fb2 and another formats.
Here is The CompletePDF Book Library.
It's free to register here to get Book file PDF Prostate Cancer - Hope Is Not A Strategy Pocket Guide.
Better diagnosis Better treatment Better prevention Better support. Consulting with researchers, health professionals and men affected by prostate cancer, our strategy — Ten years to tame prostate cancer — is based on what we know now, and what we can build on using this knowledge. These are ambitious targets, and making inroads into these areas will be expensive, but with your help in supporting us fund this research, we will be able to stop prostate cancer being a killer.
Men affected by prostate cancer tell us one of the biggest problems we need to fix is diagnosis. We want to increase the proportion of men whose aggressive prostate cancer is detected before it spreads outside the prostate. We also aim to reduce the number of unnecessary biopsies, as well as over-diagnosis and over-treatment of harmless prostate cancers. We want to only diagnose prostate cancers that need to be treated, and leave non-aggressive prostate cancers alone.
We'll work with top international researchers to develop a new risk screening tool. Combining known risk factors, this tool will establish a man's risk of getting aggressive prostate cancer, to help men and their doctors decide whether further investigation and treatment is required. The risk screening tool will revolutionise diagnosis, and is expected to be in the hands of GPs in five years. You can help fund this groundbreaking tool. But that's not all we're up to.
How prostate cancer becomes treatment resistant
With your support, we'll also fund research into new tests and drag them out of the lab and into hospitals and GP surgeries across the country. With treatments available we couldn't even dream about 20 years ago and more in the pipeline, we are making massive progress.
But there's still much to do. Many of these new treatments offer improvements, but are still nowhere near what men should expect. Although they may save your life, many leave men with life-changing side-effects, including incontinence, erectile dysfunction, and affected mental well-being.
This includes optimising drug dosage and delivery, finding the most effective treatment combinations, and clarifying the benefits or otherwise of a fixed pathway of drug or treatment use. We still don't know which treatments work best for each individual man. Your support will fund research to find the answers, so treatment is tailored for men according to what works best for them.
Ensuring this evidence is translated from the lab and into practice as early as possible will be a priority. There are also questions about whether some treatments could work even better if given earlier in the treatment pathway, such as those designed for treating advanced prostate cancer only. We need to find out whether giving these treatments to men with high risk disease that hasn't spread outside the prostate can help increase cure rates. You can help fund this research, and potentially save lives. We also need to investigate new treatment pathways for prostate cancer, and to exploit ongoing work in other cancer types or disease areas that will help us introduce effective treatments more quickly and more cheaply than just developing new treatments completely from scratch.
We need to better understand how prostate cancer starts, grows, and develops. Understanding what makes prostate cancer return, and how to stop this, is another priority area. Can a man control his risk of prostate cancer through diet, exercise or drugs?
Prostate care, testing, treatment knowledge, and support.
What role does the environment play? With your help, we will invest in research into the basic biology of prostate cancer, but only if it will significantly increase our understanding and, most importantly, inform future work in prevention.
Further research into prostate cancer prevention is a longer-term priority, and we will target men who are at highest risk of aggressive prostate cancer. And we want men to understand what the best care looks like for themselves and how to get it. We'll work in partnership with health services across the UK, urging them to pick up the baton when innovative care that makes a difference is discovered and we'll make sure prostate cancer is right at the top of the priority list for decision-makers. From left: Prof.
Observation or Active Surveillance for Prostate Cancer
Our diagnosis and treatment options have improved significantly since and, together with patient organisations, we feel that the time has come to add prostate cancer to the screening recommendations. By encouraging awareness in the general population and at-risk men in particular, interest and demand for early detection can be increased. The EAU supports patient advocacy organisations and indeed addresses potential patients directly with information campaigns.
EAU-affiliated healthcare professionals and patient organisation representatives from bladder, kidney, and prostate cancer groups came together to discuss ideas and needs and explored ways to collaborate. They lobby their national governments and generate attention among the general population.
This leaflet will plainly outline the advantages and disadvantages of PSA-based early detection, and explain possible consequences for the patient after detection. If something is detected, this might result in a biopsy, or perhaps active surveillance will suffice.
How I Chose My Prostate Cancer Treatment
At the very least, mortality will decrease. By persuading the European Commission to support screening for prostate cancer and by increasing awareness among patients, we think we can be successful in changing national healthcare legislation in European countries.
Category: Policy , International Relations. Share this on your favourite network:.